Fortitude Advisory Group L.L.C. decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 6.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 1,514 shares of the healthcare conglomerate’s stock after selling 97 shares during the period. Fortitude Advisory Group L.L.C.’s holdings in UnitedHealth Group were worth $766,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. International Assets Investment Management LLC lifted its position in shares of UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares in the last quarter. Accredited Investors Inc. lifted its position in shares of UnitedHealth Group by 9,235.4% during the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock worth $458,929,000 after buying an additional 776,516 shares in the last quarter. Raymond James & Associates increased its position in shares of UnitedHealth Group by 33.1% during the third quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock valued at $1,380,661,000 after acquiring an additional 587,088 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its position in UnitedHealth Group by 129.7% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock worth $601,951,000 after purchasing an additional 581,324 shares during the last quarter. Finally, State Street Corp raised its stake in shares of UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after purchasing an additional 563,554 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on UNH. Stephens boosted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $627.74.
Insider Buying and Selling at UnitedHealth Group
In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is owned by company insiders.
UnitedHealth Group Trading Up 2.0 %
UNH opened at $543.41 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The firm has a market capitalization of $500.09 billion, a price-to-earnings ratio of 35.06, a PEG ratio of 1.41 and a beta of 0.62. The business has a 50 day simple moving average of $541.04 and a two-hundred day simple moving average of $564.79.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the firm earned $5.83 EPS. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post 29.74 EPS for the current year.
UnitedHealth Group Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Canadian Penny Stocks: Can They Make You Rich?
- Momentum Grows for These 3 Healthcare Stocks
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Stocks Upgraded by Bank of America – Here’s Why They’re Bullish
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 2 Stocks to Benefit From China Tariff Resets: Is 60% a Bluff?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.